Patents Assigned to ENDOSURE INC.
  • Patent number: 12138057
    Abstract: A method of determining and treating disordered tissue in a patient incites energy signal generation from disordered tissue. An energy sensor structure obtains an energy signal from tissue of a patient. The obtained energy signal is compared in a processor circuit to a known energy signal of the same tissue under normal functioning of the tissue. The tissue is identified as disordered tissue when the comparing step determines that the obtained energy signal is different from the known energy signal. The disordered tissue is localized within the patient via the energy signal. A bodily disorder caused by the localized disordered tissue is diagnosed by an AI module. The bodily disorder is then treated.
    Type: Grant
    Filed: February 9, 2022
    Date of Patent: November 12, 2024
    Assignee: ENDOSURE, INC.
    Inventor: Mark D. Noar
  • Patent number: 11806161
    Abstract: A tissue disorder monitoring system includes at least two electrodes constructed and arranged to obtain analog electrical signals from a patient. An amplifier amplifies the analog electrical signals. Filter structure filters the amplified analog electrical signal. An A/D converter converts the amplified and filtered analog electrical signals to digitized electrical signals. A microprocessor circuit is constructed and arranged to execute an application that analyzes the digitized electrical signals to identify and to determine treatment data including a specific location and/or propagation of disordered tissue within the patient. A transmitter transmits data in a wireless manner. A power supply powers the device. A method locating disordered tissue in a patient is also disclosed.
    Type: Grant
    Filed: June 4, 2021
    Date of Patent: November 7, 2023
    Assignee: ENDOSURE INC.
    Inventor: Mark D. Noar